Adipokines and bone metabolism: an interplay to untangle

Journal of Endocrinological Investigation

Volumn 39, Issue 11, 2016, Pages 1359-1361

  Pepe, J ^a   Cipriani, C ^a   Cilli, M ^a   Colangelo, L ^a   Minisola, S ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOCYTOKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LEPTIN; OSTEOCALCIN; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN; TUMOR NECROSIS FACTOR;

ARTICLE; BONE DENSITY; BONE METABOLISM; CELL DIFFERENTIATION; CELL PROLIFERATION; DIABETES MELLITUS; HUMAN; INSULIN SENSITIVITY; METABOLIC SYNDROME X; NONALCOHOLIC FATTY LIVER; OBESITY; OSSIFICATION; PRIORITY JOURNAL; BONE; METABOLISM; OSTEOPOROSIS; PATHOPHYSIOLOGY;

ADIPOKINES; BONE AND BONES; HUMANS; OSTEOPOROSIS;

EID: 84991705931     PISSN: 03914097     EISSN: 17208386     Source Type: Journal    
DOI: 10.1007/s40618-016-0549-y     Document Type: Article

References (12)

1. Compston JE, Flahive J, Hosmer DW, Watts NB, Siris ES, Silverman S, Saag KG, Roux C, Rossini M, Pfeilschifter J, Nieves JW, Netelenbos JC, March L, LaCroix AZ, Hooven FH, Greenspan SL, Gehlbach SH, Díez-Pérez A, Cooper C, Chapurlat RD, Boonen S, Anderson FA Jr, Adami S, Adachi JD, Investigators GLOW (2014) Relationship of weight, height, and body mass index with fracture risk at different sites in postmenopausal women: the global longitudinal study of osteoporosis in women (GLOW). J Bone Miner Res 29:487–493
2. De Luis DA, Aller R, Izaola O, Bachiller R (2015) Role of rs6923761 gene variant in glucagon-like peptide 1 receptor in basal GLP-1 levels, cardiovascular risk factor and serum adipokine levels in naïve type 2 diabetic patients. J Endocrinol Invest 38:143–147
3. Berezin AE, Kremzer AA, Samura TA, Berezina TA, Kruzliak P (2015) Impaired immune phenotype of circulating endothelial-derived microparticles in patients with metabolic syndrome and diabetes mellitus. J Endocrinol Invest 38:865–874
4. Chen XX, Yang T (2015) Roles of leptin in bone metabolism and bone diseases. J Bone Miner Metab 33:474–485
5. Sawicka K, Krasowska D (2016) Adipokines in connective tissue diseases. Clin Exp Rheumatol (Epub ahead of print)
6. Delfini E, Petramala L, Caliumi C, Cotesta D, De Toma G, Cavallaro G, Panzironi G, Diacinti D, Minisola S, D’ Erasmo E, Mazzuoli GF, Letizia C (2007) Circulating leptin and adiponectin levels in patients with primary hyperparathyroidism. Metabolism 56:30–36
7. Cipriani C, Pepe J, Piemonte S, Colangelo L, Cilli M, Minisola S (2014) Vitamin d and its relationship with obesity and muscle. Int J Endocrinol 2014:841248
8. Upala S, Sanguankeo A, Jaruvongvanich V (2015) Association between nonalcoholic fatty liver disease and bone mineral density: a systematic review and meta-analysis. J Endocrinol Invest 38:931–932
9. Biver E, Salliot C, Combescure C, Gossec L, Hardouin P, Legroux-Gerot I, Cortet B (2011) Influence of adipokines and ghrelin on bone mineral density and fracture risk: a systematic review and meta-analysis. J Clin Endocrinol Metab 96:2703–2713
10. Arama V, Munteanu DI, Streinu Cercel A, Ion DA, Mihailescu R, Tiliscan C, Tudor AM, Arama SS (2014) Lipodystrophy syndrome in HIV treatment-multiexperienced patients: implication of resistin. J Endocrinol Invest 37:533–539
11. Li XP, Zeng S, Wang M, Wu XP, Liao EY (2014) Relationships between serum omentin-1, body fat mass and bone mineral density in healthy Chinese male adults in Changsha area. J Endocrinol Invest 37:991–1000
12. Menzel J, Di Giuseppe R, Biemann R, Aleksandrova K, Kuxhaus O, Wittenbecher C, Fritsche A, Schulze MB, Isermann B, Boeing H, Weikert C (2016) Association between omentin-1, adiponectin and bone health under consideration of osteoprotegerin as possible mediator. J Endocrinol Invest. doi:10.1007/s40618-016-0544-3